| Literature DB >> 33975652 |
Talat Bilal Yasoob1,2,3, Defu Yu1,2, Abdur Rauf Khalid1,2,4, Zhen Zhang1,2, Xiaofeng Zhu1,2, Heba M Saad1,2, Suqin Hang5,6.
Abstract
BACKGROUND: Heat stress (HS) disrupts the gut barrier allowing the uptake of lipopolysaccharide (LPS) and leads to an inflammatory response and changes in gut microbiota composition. Moringa oleifera leaf powder (MOLP) has been proposed to combat HS, yet its alleviate role is currently under investigation. The current study investigated the effects of chronic HS and MOLP supplementation on changes in redox status and immune response of cecal mucosa along with alteration in cecal microbiota.Entities:
Keywords: Cecal microbiota; Heat stress; Moringa oleifera leaf powder; Rabbits; Short chain fatty acids
Year: 2021 PMID: 33975652 PMCID: PMC8114525 DOI: 10.1186/s40104-021-00586-y
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Fig. 1Effect of HS and Moringa oleifera leaf powder (MOLP) supplementation on organ index of cecum (n = 7 per group). MOLP: Moringa oleifera leaf powder; CON: control; HS: heat stress; HSM: heat stress with MOLP supplementation. All data is shown as mean values ± standard error of mean (SEM). a,b Means within groups (columns) with different superscript letters are significantly different (P < 0.05)
Fig. 2Effect of HS and MOLP supplementation on biochemical traits of cecal mucosa in NZW rabbits (n = 7 per group). MOLP: Moringa oleifera leaf powder; CON: control; HS: heat stress; HSM: heat stress with MOLP supplementation; CAT: catalase; SOD: superoxide dismutase; GST: glutathione S-transferase; MDA: malonaldehyde; LDH: lactate dehydrogenase. All data is shown as mean values ± standard error of the mean (SEM). a,b Means within groups (columns) with different superscript letters are significantly different (P < 0.05)
Fig. 3Effect of HS and MOLP supplementation on LPS, SIgA and markers of inflammation in cecal mucosa of NZW rabbits (n = 7 per group). MOLP: Moringa oleifera leaf powder; CON: control; HS: heat stress; HSM: heat stress with MOLP supplementation; LPS: lipopolysaccharide; sIgA: secretory immunoglobulin A; TNF-α: tumor necrosis factor alpha; IL-1α: interleukin-1α; IL-1β: interleukin-1β; IL-6: interleukin-6; MPO: myeloperoxidase. All data is shown as mean values ± standard error of the mean (SEM). a,b Means within groups (columns) with different superscript letters are significantly different (P < 0.05)
Fig. 4KEGG route enrichment statistics. The X-axis shows the enrichment factor; the Y-axis corresponds to the KEGG pathway. The color of the dot represents the q value, and the dot size represents the number of differentially expressed genes (DEGs) mapped to the reference path. a, b, c represent statistics of the KEGG pathway enrichment of the DEGs of the HS vs. CON, HSM vs. CON, and HSM vs. HS groups, respectively
Effect of HS and MOLP supplementation on the log fold change (logFC) of differentially expressed genes (DEGs) in pairwise comparison (HS vs. CON, HSM vs. CON and HSM vs. HS) that encode proteins in allograft rejection pathway
| Gene symbol | HS vs. CON | HSM vs. CON | Gene name/Predicted function | ||||
|---|---|---|---|---|---|---|---|
| Inflammatory factor | 3.97 | < 0.0001 | 0.000223 | Interferon gamma precursor | |||
| −3.33 | < 0.0001 | −4.57 | < 0.0001 | Interleukin-12 subunit beta | |||
| 1.81 | < 0.0001 | 1.35 | < 0.0001 | Ig gamma chain C region | |||
| 11.16 | 0.004 | 10.92 | 0.004 | CD40 ligand | |||
| −1.01 | < 0.0001 | < 0.0001 | Perforin-1 | ||||
| −2.44 | < 0.0001 | −3.02 | < 0.0001 | Granzyme H | |||
| < 0.0001 | Duodenase-1 | ||||||
| 0.0014 | Interleukin-10 isoform X1 | ||||||
| −1.72 | 0.0004 | 0.0055 | T-lymphocyte activation antigen CD86 precursor | ||||
MHC (major histocompatibility complex) | < 0.0001 | Histocompatibility antigen DM heterodimer light chain-like precursor | |||||
| −1.18 | < 0.0001 | < 0.0001 | HLA class II histocompatibility antigen, DO beta chain isoform X2 | ||||
| 1.44 | < 0.0001 | < 0.0001 | HLA class II histocompatibility antigen, DQ beta 1 chain isoform X2 | ||||
| 1.12 | < 0.0001 | < 0.0001 | SLA class II histocompatibility antigen, DQ haplotype D alpha chain isoform X2 | ||||
| < 0.0001 | HLA class II histocompatibility antigen, DRB1–4 beta chain | ||||||
| −1.12 | 0.021 | HLA class II histocompatibility antigen, DRB1–1 beta chain isoform X1 | |||||
| < 0.0001 | MHC class I antigen-like isoform X1 | ||||||
| −1.36 | < 0.0001 | < 0.0001 | HLA class I histocompatibility antigen, B-7 alpha chain isoform X1 | ||||
| < 0.0001 | RLA class I histocompatibility antigen, alpha chain 19–1 precursor | ||||||
| −1.97 | < 0.0001 | < 0.0001 | RLA class I histocompatibility antigen, alpha chain 11/11 | ||||
| 1.83 | < 0.0001 | 1.38 | < 0.0001 | RLA class I histocompatibility antigen, alpha chain 11/11 |
It may be noted that in pairwise comparison, first group (e.g. in HS vs. CON comparison, the HS group) represents the up- or down-regulated DEGs as compared to other group when logFC value is positive or negative respectively
The effect of HS and MOLP supplementation on the logfold change (logFC) of differentially expressed genes (DEGs) in pairwise comparison (HS vs. CON, HSM vs. CON and HSM vs. HS) that encode proteins in fat digestion and absorption pathway
| Gene name | HS vs CON | HSM vs CON | HSM vs. HS | Predicted function | |||
|---|---|---|---|---|---|---|---|
| 15.69 | < 0.0001 | 16.48 | < 0.0001 | Apolipoprotein A-IV precursor | |||
| 4.36 | < 0.0001 | 5.01 | Apolipoprotein A-I preproprotein | ||||
| 13.49 | < 0.0001 | 14.14 | < 0.0001 | Fatty acid-binding protein, liver | |||
| 2.62 | < 0.0001 | 5.01 | < 0.0001 | 2.39 | < 0.0001 | Fatty acid-binding protein, intestinal | |
| 1.29 | < 0.0001 | 1.32 | < 0.0001 | Microsomal triglyceride transfer protein large subunit | |||
| 8.89 | < 0.0001 | 9.97 | < 0.0001 | Phospholipase A2, membrane associated-like | |||
| −1.71 | 0.006 | −2.69 | < 0.0001 | Pancreatic triacylglycerol lipase-like | |||
| 1.84 | < 0.0001 | −1.28 | < 0.0001 | Phospholipase A2, membrane-associated | |||
| −11.75 | 0.015 | −11.75 | 0.015 | Group IIF secretory phospholipase A2 | |||
| 2.06 | 0.012 | 1.35 | 0.016 | Group XIIB secretory phospholipase A2-like protein isoform X2 | |||
| −1.83 | < 0.0001 | Calcium-dependent phospholipase A2 | |||||
| 12.80 | < 0.0001 | 5.81 | < 0.0001 | Niemann-Pick C1-like protein 1 precursor | |||
| 1.04 | < 0.0001 | Apolipoprotein B | |||||
| 9.84 | 0.015 | 9.84 | 0.008 | ATP-binding cassette sub-family G member 8 isoform X2 | |||
| −2.51 | < 0.0001 | −1.45 | < 0.0001 | 2-acylglycerol O-acyltransferase 2-B | |||
| 1.60 | < 0.0001 | Phospholipase A2 |
It may be noted that in pairwise comparison, first group (e.g. in HS vs. CON comparison, the HS group) represents the up- or down-regulated DEGs as compared to other group when logFC value is positive or negative respectively
Effect of HS and MOLP supplementation on microbiota composition in cecal digesta of NZW rabbits at phylum level (relative abundance of top 5 phyla)
| Items | CON | HS | HSM | SEM | |
|---|---|---|---|---|---|
| Firmicutes | 57.83 | 59.18 | 66.15 | 2.31 | 0.299 |
| Bacteroidetes | 30.61 | 29.10 | 21.04 | 2.35 | 0.206 |
| Verrucomicrobia | 9.24 | 7.92 | 8.27 | 1.50 | 0.943 |
| Proteobacteria | 0.56b | 1.05a | 0.62b | 0.07 | 0.002 |
| Actinobacteria | 0.36b | 0.54b | 1.21a | 0.15 | 0.037 |
MOLP Moringa oleifera leaf powder; CON control; HS Heat stress; HSM Heat stress with Moringa supplementation. All data is presented as mean values ± standard error of mean (SEM). a,b Means in rows with different superscript letters are significantly different (P < 0.05)
Fig. 5Differential analysis of microbiota community within groups i.e. CON, HS and HSM (n = 7 per group). Linear discrimination analysis (LDA) coupled with effect size (LEfSe) was used to identify the most differentially abundant taxa among the three groups. Only the results meeting an LDA significant threshold of > 3 were shown
Effect of HS and MOLP supplementation on the concentrations of short chain fatty acids (SCFAs) in cecal digesta in heat-stressed NZW rabbits (n = 7 per group)
| Item, mmol/L | CON | HS | HSM | SEM | |
|---|---|---|---|---|---|
| Acetic acid | 25.3a | 21.4b | 38.0a | 2.97 | 0.004 |
| Propionic acid | 9.50 | 9.60 | 5.80 | 1.33 | 0.47 |
| Butyric acid | 9.20b | 9.00b | 11.5a | 1.19 | 0.014 |
| Iso-butyric acid | 0.90 | 1.70 | 1.80 | 0.27 | 0.49 |
| Valeric acid | 1.10 | 1.00 | 0.90 | 0.67 | 0.91 |
| Iso-valeric acid | 0.30 | 0.30 | 0.50 | 0.07 | 0.39 |
| Total SCFAs | 45.3 | 41.2 | 53.5 | 4.67 | 0.28 |
MOLP Moringa oleifera leaf powder; CON Control; HS Heat stress; HSM Heat stress with MOLP supplementation. All data is presented as mean values ± standard error of mean (SEM). a,b Means in rows with different superscript letters are significantly different (P < 0.05)